Article Information
PubMed
Print ISSN
Online ISSN
History
- Received December 27, 2006
- Accepted March 22, 2007
- Published online May 14, 2007.
Article Versions
- Earlier version (March 26, 2007 - 11:34).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Jeffrey R. Crosby,
- Mausumee Guha,
- David Tung,
- Doreen A. Miller,
- Brianna Bender,
- Thomas P. Condon,
- Cathie York-DeFalco,
- Richard S. Geary,
- Brett P. Monia,
- James G. Karras and
- Susan A. Gregory
- Departments of Antisense Drug Discovery (J.R.C., D.A.M., B.B., C.Y.-D., B.P.M.), Pharmacokinetics (R.S.G.), and Clinical Development (J.G.K., S.A.G.), ISIS Pharmaceuticals, Carlsbad, California; Kalypsys Pharmaceuticals, San Diego, California (M.G.); Pfizer, Chesterfield, Missouri (D.T.); and CombinatoRx, Helios, Singapore (T.P.C.)
- Address correspondence to:
Dr. Jeffrey R. Crosby, Antisense Drug Discovery, Isis Pharmaceuticals, 1896 Rutherford Rd., Carlsbad, CA 92008. E-mail: jcrosby{at}isisph.com
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement